Paper Details

  1. Home
  2. Paper Details

Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections.

Author: HoepelmanI M, Rozenberg-ArskaM, VerhoefJ

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Ceftriaxone monotherapy was found to be as effective and less costly than a combination therapy of cefuroxime and gentamicin in the initial management of patients with suspected serious bacterial infections.
Paper Details　
Original Abstract of the Article :
To compare the efficacy of once daily monotherapy with that of standard combination antibiotic therapy for the initial management of patients suspected of serious bacterial infections, 105 patients were randomised to treatment with ceftriaxone alone (53 patients) or to a combination of cefuroxime an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0140-6736(88)92121-6

データ提供：米国国立医学図書館（NLM）

Ceftriaxone: A Powerful Weapon in the Fight Against Bacterial Infections

This research explores the efficacy of ceftriaxone, a powerful antibiotic, in treating serious bacterial infections. The study, like a seasoned camel navigating the vast desert of infectious disease research, compares the effectiveness of ceftriaxone monotherapy with a combination of cefuroxime and gentamicin. The findings demonstrate that ceftriaxone, administered once daily, is at least as effective as the combination therapy, offering a more convenient and cost-effective approach to managing serious bacterial infections.

A Promising New Weapon in the Fight Against Infections

This research highlights the effectiveness and cost-effectiveness of ceftriaxone in treating serious bacterial infections. The study's findings suggest that ceftriaxone, with its convenient once-daily administration, offers a valuable option for managing these challenging conditions.

Navigating the Desert of Bacterial Infections

This research provides valuable insights for healthcare professionals managing patients with serious bacterial infections. The findings emphasize the effectiveness and cost-effectiveness of ceftriaxone, offering a promising new tool for combating these potentially dangerous conditions.

Dr.Camel's Conclusion

This research underscores the effectiveness of ceftriaxone in treating serious bacterial infections. The study's findings demonstrate that ceftriaxone, with its convenient once-daily administration and cost-effectiveness, offers a valuable option for managing these challenging conditions. This discovery is like finding a hidden spring in the desert of bacterial infections, offering a potential source of relief for those struggling with these potentially dangerous conditions.

Date :
  1. Date Completed 1988-07-08
  2. Date Revised 2019-06-11
Further Info :

Pubmed ID

2897559

DOI: Digital Object Identifier

10.1016/s0140-6736(88)92121-6

Related Literature

Article Analysis
・Side Effects of cefuroxime
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.